Achalasia.
Journal
Nature reviews. Disease primers
ISSN: 2056-676X
Titre abrégé: Nat Rev Dis Primers
Pays: England
ID NLM: 101672103
Informations de publication
Date de publication:
05 05 2022
05 05 2022
Historique:
accepted:
01
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
Achalasia is a rare disorder of the oesophageal smooth muscle characterized by impaired relaxation of the lower oesophageal sphincter (LES) and absent or spastic contractions in the oesophageal body. The key pathophysiological mechanism is loss of inhibitory nerve function that probably results from an autoimmune attack targeting oesophageal myenteric nerves through cell-mediated and, possibly, antibody-mediated mechanisms. Achalasia incidence and prevalence increase with age, but the disorder can affect all ages and both sexes. Cardinal symptoms consist of dysphagia, regurgitation, chest pain and weight loss. Several years can pass between symptom onset and an achalasia diagnosis. Evaluation starts with endoscopy to rule out structural causes, followed by high-resolution manometry and/or barium radiography. Functional lumen imaging probe can provide complementary evidence. Achalasia subtypes have management and prognostic implications. Although symptom questionnaires are not useful for diagnosis, the Eckardt score is a simple symptom scoring scale that helps to quantify symptom response to therapy. Oral pharmacotherapy is not particularly effective. Botulinum toxin injection into the LES can temporize symptoms and function as a bridge to definitive therapy. Pneumatic dilation, per-oral endoscopic myotomy and laparoscopic Heller myotomy can provide durable symptom benefit. End-stage achalasia with a dilated, non-functioning oesophagus may require oesophagectomy or enteral feeding into the stomach. Long-term complications can, rarely, include oesophageal cancer, but surveillance recommendations have not been established.
Identifiants
pubmed: 35513420
doi: 10.1038/s41572-022-00356-8
pii: 10.1038/s41572-022-00356-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
28Informations de copyright
© 2022. Springer Nature Limited.
Références
Pandolfino, J. E. & Gawron, A. J. Achalasia: a systematic review. JAMA 313, 1841–1852 (2015).
pubmed: 25965233
Vaezi, M. F. et al. ACG clinical guidelines: diagnosis and management of achalasia. Am. J. Gastroenterol. 115, 1393–1411 (2020).
pubmed: 32773454
Yadlapati, R. et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0((c)). Neurogastroenterol. Motil. 33, e14058 (2021).
pubmed: 33373111
pmcid: 8034247
Gergely, M. et al. Duration of symptoms and manometric parameters offer clues to diagnosis of pseudoachalasia. Neurogastroenterol. Motil. 33, e13965 (2021).
pubmed: 32779296
Furuzawa-Carballeda, J. et al. Achalasia — an autoimmune inflammatory disease: a cross-sectional study. J. Immunol. Res. 2015, 729217 (2015).
pubmed: 26078981
pmcid: 4452860
De Giorgio, R. et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am. J. Gastroenterol. 94, 2357–2362 (1999).
pubmed: 10483991
Kilic, A. et al. Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J. Surg. Res. 143, 177–182 (2007).
pubmed: 17950090
Moses, P. L. et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 52, 629–636 (2003).
pubmed: 12692044
pmcid: 1773656
Gaber, C. E. et al. Autoimmune and viral risk factors are associated with achalasia: a case-control study. Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.14312 (2021).
doi: 10.1111/nmo.14312
pubmed: 34957646
Naik, R. D. et al. Association of achalasia with active Varicella zoster virus infection of the esophagus. Gastroenterology 161, 719–721 e2 (2021).
pubmed: 33932481
Facco, M. et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am. J. Gastroenterol. 103, 1598–1609 (2008).
pubmed: 18557707
Sodikoff, J. B. et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol. Motil. 28, 139–145 (2016).
pubmed: 26542087
Reddy, C. A. et al. Per-oral endoscopic myotomy biopsies of achalasia patients reveal Schwann cell depletion in the muscularis propria. Clin. Gastroenterol. Hepatol. 19, 1294–1295 (2021).
pubmed: 32668343
Sato, H. et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J. Gastroenterol. 54, 621–627 (2019).
pubmed: 30607612
van Hoeij, F. B. et al. Incidence and costs of achalasia in The Netherlands. Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.13195 (2018).
doi: 10.1111/nmo.13195
pubmed: 28836740
Harvey, P. R. et al. Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. Gut 68, 790–795 (2019).
pubmed: 29925629
Sadowski, D. C. et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol. Motil. 22, e256–e261 (2010).
pubmed: 20465592
Samo, S. et al. Incidence and prevalence of achalasia in central Chicago, 2004-2014, since the widespread use of high-resolution manometry. Clin. Gastroenterol. Hepatol. 15, 366–373 (2017).
pubmed: 27581064
Duffield, J. A. et al. Incidence of achalasia in South Australia based on esophageal manometry findings. Clin. Gastroenterol. Hepatol. 15, 360–365 (2017).
pubmed: 27266979
Gaber, C. E. et al. Epidemiologic and economic burden of achalasia in the United States. Clin. Gastroenterol. Hepatol. 20, 342–352.e5. (2021).
pubmed: 33652152
Roman, S. et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: a randomized multicenter study. Am. J. Gastroenterol. 111, 372–80. (2016).
pubmed: 26832656
Wadhwa, V. et al. Changing trends in age, gender, racial distribution and inpatient burden of achalasia. Gastroenterol. Res. 10, 70–77 (2017).
Gregersen, H. & Lo, K. M. Pathophysiology and treatment of achalasia in a muscle mechanical perspective. Ann. N. Y. Acad. Sci. 1434, 173–184 (2018).
pubmed: 29756656
Behar, J. & Biancani, P. Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology 105, 111–118 (1993).
pubmed: 8099885
Sifrim, D., Janssens, J. & Vantrappen, G. Failing deglutitive inhibition in primary esophageal motility disorders. Gastroenterology 106, 875–882 (1994).
pubmed: 8143993
Fornari, F. et al. Multiple rapid swallowing: a complementary test during standard oesophageal manometry. Neurogastroenterol. Motil. 21, 718–e41 (2009).
pubmed: 19222762
Savojardo, D. et al. Multiple rapid swallowing in idiopathic achalasia: evidence for patients’ heterogeneity. Neurogastroenterol. Motil. 19, 263–269 (2007).
pubmed: 17391242
Kushnir, V., Sayuk, G. S. & Gyawali, C. P. Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry. Neurogastroenterol. Motil. 24, 1069–e561 (2012).
pubmed: 22788116
pmcid: 3508286
Murray, J. A. et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology 109, 1241–1248 (1995).
pubmed: 7557091
Aggestrup, S. et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 84, 924–927 (1983).
pubmed: 6832568
Mearin, F. et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur. J. Clin. Invest. 23, 724–728 (1993).
pubmed: 7508398
Yamato, S., Saha, J. K. & Goyal, R. K. Role of nitric oxide in lower esophageal sphincter relaxation to swallowing. Life Sci. 50, 1263–1272 (1992).
pubmed: 1373790
Dodds, W. J. et al. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 80, 327–333 (1981).
pubmed: 7450423
Cohen, S., Fisher, R. & Tuch, A. The site of denervation in achalasia. Gut 13, 556–558 (1972).
pubmed: 5069732
pmcid: 1412277
Booy, J. D. et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis. Esophagus 25, 209–213 (2012).
pubmed: 21899655
King, D. et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am. J. Gastroenterol. 116, 416–419 (2021).
pubmed: 33105192
Romero-Hernández, F. et al. Autoimmune comorbidity in achalasia patients. J. Gastroenterol. Hepatol. 33, 203–208 (2018).
pubmed: 28568312
Sara, C. et al. Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases. Dis. Esophagus 34, doaa072 (2021).
pubmed: 32766709
Becker, J. et al. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia. Eur. J. Gastroenterol. Hepatol. 28, 689–695 (2016).
pubmed: 26882171
Becker, J. et al. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur. J. Hum. Genet. 24, 1228–1231 (2016).
pubmed: 26733285
pmcid: 4970678
Furuzawa-Carballeda, J. et al. An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia. PLoS ONE 13, e0201676 (2018).
pubmed: 30092016
pmcid: 6084941
Vackova, Z. et al. First genotype-phenotype study reveals HLA-DQβ1 insertion heterogeneity in high-resolution manometry achalasia subtypes. United European Gastroenterol. J. 7, 45–51 (2019).
pubmed: 30788115
Goldblum, J. R., Rice, T. W. & Richter, J. E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 111, 648–654 (1996).
pubmed: 8780569
Villanacci, V. et al. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J. Clin. Gastroenterol. 44, 407–410 (2010).
pubmed: 19834336
Clark, S. B. et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am. J. Surg. Pathol. 24, 1153–1158 (2000).
pubmed: 10935657
Spechler, S. J., Konda, V. & Souza, R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am. J. Gastroenterol. 113, 1594–1599 (2018).
pubmed: 30315308
Jin, H. et al. Activated eosinophils are present in esophageal muscle in patients with achalasia of the esophagus. Med. Sci. Monit. 24, 2377–2383 (2018).
pubmed: 29672471
pmcid: 5928914
Visaggi, P. et al. Systematic review: esophageal motility patterns in patients with eosinophilic esophagitis. Dig. Liver Dis. https://doi.org/10.1016/j.dld.2022.01.003 (2022).
doi: 10.1016/j.dld.2022.01.003
pubmed: 35090825
Nelson, M. et al. Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation. Neurogastroenterol. Motil. 33, e14055 (2021).
pubmed: 33280206
Zarate, N. et al. Intramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasia. Neurogastroenterol. Motil. 18, 556–568 (2006).
pubmed: 16771771
Ruiz-de-Leon, A. et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig. Dis. Sci. 47, 15–19 (2002).
pubmed: 11837716
Storch, W. B. et al. Autoantibodies to Auerbach’s plexus in achalasia. Cell Mol. Biol. 41, 1033–1038 (1995).
pubmed: 8747084
Verne, G. N., Sallustio, J. E. & Eaker, E. Y. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig. Dis. Sci. 42, 307–313 (1997).
pubmed: 9052511
Robertson, C. S., Martin, B. A. & Atkinson, M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 34, 299–302 (1993).
pubmed: 8386130
pmcid: 1374131
Castagliuolo, I. et al. Esophageal achalasia: is the herpes simplex virus really innocent? J. Gastrointest. Surg. 8, 24–30 (2004).
pubmed: 14746832
Birgisson, S. et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig. Dis. Sci. 42, 300–306 (1997).
pubmed: 9052510
Boeckxstaens, G. E. Achalasia: virus-induced euthanasia of neurons? Am. J. Gastroenterol. 103, 1610–1612 (2008).
pubmed: 18557706
Boeckxstaens, G. E., Zaninotto, G. & Richter, J. E. Achalasia. Lancet 383, 83–93 (2014).
pubmed: 23871090
Wong, R. K. et al. Significant DQw1 association in achalasia. Dig. Dis. Sci. 34, 349–52. (1989).
pubmed: 2920639
Kilpatrick, Z. M. & Milles, S. S. Achalasia in mother and daughter. Gastroenterology 62, 1042–1046 (1972).
pubmed: 5029070
Monnig, P. J. Familial achalasia in children. Ann. Thorac. Surg. 49, 1019–1022 (1990).
pubmed: 2369177
Brooks, B. P. et al. Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000-2005. Clin. Genet. 68, 215–221 (2005).
pubmed: 16098009
Koehler, K. et al. Mutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction. Am. J. Hum. Genet. 93, 727–734 (2013).
pubmed: 24035193
pmcid: 3791256
Goldblum, J. R. et al. Achalasia. A morphologic study of 42 resected specimens. Am. J. Surg. Pathol. 18, 327–337 (1994).
pubmed: 8141427
Faussone-Pellegrini, M. S. & Cortesini, C. The muscle coat of the lower esophageal sphincter in patients with achalasia and hypertensive sphincter. An electron microscopic study. J. Submicrosc. Cytol. 17, 673–685 (1985).
pubmed: 4078952
Bonora, E. et al. INPP4B overexpression and c-KIT downregulation in human achalasia. Neurogastroenterol. Motil. 30, e13346 (2018).
pubmed: 29644781
Tustumi, F. et al. Achalasia: a syndrome. Neurogastroenterol. Motil. 33, e14089 (2021).
pubmed: 33506560
Kahrilas, P. J. & Boeckxstaens, G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry. Gastroenterology 145, 954–965 (2013).
pubmed: 23973923
Mittal, R. K., Hong, S. J. & Bhargava, V. Longitudinal muscle dysfunction in achalasia esophagus and its relevance. J. Neurogastroenterol. Motil. 19, 126–136 (2013).
pubmed: 23667744
pmcid: 3644649
Kim, T. H. et al. Esophageal contractions in type 3 achalasia esophagus: simultaneous or peristaltic? Am. J. Physiol. Gastrointest. Liver Physiol. 310, G689–G695 (2016).
pubmed: 26950858
pmcid: 4867325
Bruley des Varannes, S. et al. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 55, 319–326 (2006).
pubmed: 16105888
Vaezi, M. F., Pandolfino, J. E. & Vela, M. F. ACG clinical guideline: diagnosis and management of achalasia. Am. J. Gastroenterol. 108, 1238–1249 (2013). quiz 1250.
pubmed: 23877351
Koppman, J. S. et al. Esophageal motility disorders in the morbidly obese population. Surg. Endosc. 21, 761–764 (2007).
pubmed: 17285388
Miller, J., Khlevner, J. & Rodriguez, L. Upper gastrointestinal functional and motility disorders in children. Pediatr. Clin. North. Am. 68, 1237–1253 (2021).
pubmed: 34736587
Franklin, A. L., Petrosyan, M. & Kane, T. D. Childhood achalasia: a comprehensive review of disease, diagnosis and therapeutic management. World J. Gastrointest. Endosc. 6, 105–111 (2014).
pubmed: 24748917
pmcid: 3985150
Eckardt, V. F., Aignherr, C. & Bernhard, G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 103, 1732–1738 (1992).
pubmed: 1451966
Patel, D. A. et al. Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation. Dis. Esophagus 30, dow028 (2017).
Urbach, D. R. et al. A measure of disease-specific health-related quality of life for achalasia. Am. J. Gastroenterol. 100, 1668–1676 (2005).
pubmed: 16144120
Tsuboi, K. et al. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion 85, 236–242 (2012).
pubmed: 22472689
Chan, W. W., Haroian, L. R. & Gyawali, C. P. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg. Endosc. 25, 2943–2949 (2011).
pubmed: 21424193
Iwakiri, K. et al. The appearance of rosette-like esophageal folds (“esophageal rosette”) in the lower esophagus after a deep inspiration is a characteristic endoscopic finding of primary achalasia. J. Gastroenterol. 45, 422–425 (2010).
pubmed: 20013295
Gomi, K. et al. New endoscopic classification of the cardiac orifice in esophageal achalasia: champagne glass sign. Dig. Endosc. 28, 645–649 (2016).
pubmed: 26969481
Hoversten, P., Otaki, F. & Katzka, D. A. Course of esophageal candidiasis and outcomes of patients at a single center. Clin. Gastroenterol. Hepatol. 17, 200–202.e1 (2019).
pubmed: 29702297
Carlson, D. A. et al. Diagnosis of esophageal motility disorders: esophageal pressure topography vs. conventional line tracing. Am. J. Gastroenterol. 110, 967–977 (2015).
pubmed: 26032151
pmcid: 4587659
Soudagar, A. S., Sayuk, G. S. & Gyawali, C. P. Learners favour high resolution oesophageal manometry with better diagnostic accuracy over conventional line tracings. Gut 61, 798–803 (2012).
pubmed: 21997554
Rohof, W. O. et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 144, 718–725 (2013). quiz e13-14.
pubmed: 23277105
Pandolfino, J. E. et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 135, 1526–1533 (2008).
pubmed: 18722376
Ghosh, S. K. et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G878–G885 (2007).
pubmed: 17690172
Kahrilas, P. J. et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol. Motil. 27, 160–174 (2015).
pubmed: 25469569
Ponds, F. A. et al. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.12908 (2017).
doi: 10.1111/nmo.12908
pubmed: 28836740
Khan, M. A. et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig. Dis. Sci. 62, 35–44 (2017).
pubmed: 27858325
van Hoeij, F. B., Smout, A. J. & Bredenoord, A. J. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol. Motil. 27, 1310–1316 (2015).
pubmed: 26095469
Biasutto, D. et al. Rapid drink challenge test during esophageal high resolution manometry in patients with esophago-gastric junction outflow obstruction. Neurogastroenterol. Motil. 30, e13293 (2018).
pubmed: 29356303
Babaei, A., Shad, S. & Massey, B. T. Motility patterns following esophageal pharmacologic provocation with amyl nitrite or cholecystokinin during high-resolution manometry distinguish idiopathic vs opioid-induced type 3 achalasia. Clin. Gastroenterol. Hepatol. 18, 813–821.e1 (2020).
pubmed: 31419570
Babaei, A. et al. Pharmacologic interrogation of patients with esophagogastric junction outflow obstruction using amyl nitrite. Neurogastroenterol. Motil. 31, e13668 (2019).
pubmed: 31236998
pmcid: 6693956
Porter, R. F. & Gyawali, C. P. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol. Motil. 23, 139–144 (2011).
pubmed: 20939855
Gyawali, C. P. et al. ACG clinical guidelines: clinical use of esophageal physiologic testing. Am. J. Gastroenterol. 115, 1412–1428 (2020).
pubmed: 32769426
Blonski, W. et al. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am. J. Gastroenterol. 113, 196–203 (2018).
pubmed: 29257145
Kostic, S. et al. Timed barium esophagogram in the assessment of patients with achalasia: reproducibility and observer variation. Dis. Esophagus 18, 96–103 (2005).
pubmed: 16053484
Rohof, W. O., Lei, A. & Boeckxstaens, G. E. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am. J. Gastroenterol. 108, 49–55 (2013).
pubmed: 23007004
Savarino, E. et al. Use of the functional lumen imaging probe in clinical esophagology. Am. J. Gastroenterol. 115, 1786–1796 (2020).
pubmed: 33156096
Carlson, D. A. et al. Evaluation of esophageal motility utilizing the functional lumen imaging probe. Am. J. Gastroenterol. 111, 1726–1735 (2016).
pubmed: 27725650
pmcid: 5224528
Carlson, D. A. et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin. Gastroenterol. Hepatol. 14, 1502–1506 (2016).
pubmed: 27062902
pmcid: 5028229
Carlson, D. A. et al. Prediction of esophageal retention: a study comparing high-resolution manometry and functional luminal imaging probe panometry. Am. J. Gastroenterol. 116, 2032–2041 (2021).
pubmed: 34388142
Carlson, D. A. et al. The functional lumen imaging probe detects esophageal contractility not observed with manometry in patients with achalasia. Gastroenterology 149, 1742–1751 (2015).
pubmed: 26278501
Carlson, D. A. et al. Classifying esophageal motility by FLIP Panometry: A Study of 722 subjects with manometry. Am. J. Gastroenterol. 116, 2357–2366 (2021).
pubmed: 34668487
Ponds, F. A. et al. Diagnostic features of malignancy-associated pseudoachalasia. Aliment. Pharmacol. Ther. 45, 1449–1458 (2017).
pubmed: 28382674
Lynch, K. L. et al. Clinical presentation and disease course of patients with esophagogastric junction outflow obstruction. Dis. Esophagus 30, dox004 (2017).
Lucchinetti, C. F., Kimmel, D. W. & Lennon, V. A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50, 652–657 (1998).
pubmed: 9521251
Bredenoord, A. J. et al. Esophagogastric junction outflow obstruction. Neurogastroenterol. Motil. 33, e14193 (2021).
pubmed: 34120375
de Oliveira, R. B. et al. The spectrum of esophageal motor disorders in Chagas’ disease. Am. J. Gastroenterol. 90, 1119–1124 (1995).
pubmed: 7611209
Dantas, R. O. Management of esophageal dysphagia in Chagas disease. Dysphagia 36, 517–522 (2021).
pubmed: 33855597
Ghisa, M. et al. Achalasia and obstructive motor disorders are not uncommon in patients with eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 19, 1554–1563 (2021).
pubmed: 32763482
Savarino, E. et al. Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin. Gastroenterol. Hepatol. 9, 1104–1106 (2011).
pubmed: 21839711
Ikeda, H. et al. Diagnosis of congenital esophageal stenosis in adults and treatment with peroral endoscopic myotomy. Ann. Gastroenterol. 34, 493–500 (2021).
pubmed: 34276187
pmcid: 8276369
Triadafilopoulos, G. et al. Changes in high-resolution manometric diagnosis over time: implications for clinical decision-making. Dis. Esophagus 33, doz094 (2020).
pubmed: 31909786
Gelfond, M., Rozen, P. & Gilat, T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology 83, 963–969 (1982).
pubmed: 6288509
Bortolotti, M. & Labo, G. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 80, 39–44 (1981).
pubmed: 7450409
Bortolotti, M. et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 118, 253–257 (2000).
pubmed: 10648452
Oude Nijhuis, R. A. B. et al. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol. J. 8, 13–33 (2020).
pubmed: 32213062
pmcid: 7005998
Vaezi, M. F. & Richter, J. E. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am. J. Gastroenterol. 94, 3406–3412 (1999).
pubmed: 10606295
Bassotti, G. & Annese, V. Review article: pharmacological options in achalasia. Aliment. Pharmacol. Ther. 13, 1391–1396 (1999).
pubmed: 10571593
Weusten, B. et al. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 52, 498–515 (2020).
pubmed: 32375192
Weusten, B. et al. Endoscopic management of gastrointestinal motility disorders - part 2: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 52, 600–614 (2020).
pubmed: 32462649
Khashab, M. A. et al. ASGE guideline on the management of achalasia. Gastrointest. Endosc. 91, 213–227.e6 (2020).
pubmed: 31839408
Annese, V. et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 111, 1418–1424 (1996).
pubmed: 8942719
van Hoeij, F. B. et al. Complications of botulinum toxin injections for treatment of esophageal motility disorders. Dis. Esophagus 30, dote12491 (2016).
van Hoeij, F. B. et al. Efficacy and safety of pneumatic dilation in achalasia: a systematic review and meta-analysis. Neurogastroenterol. Motil. 31, e13548 (2019).
pubmed: 30697952
pmcid: 6849773
Boeckxstaens, G. E. et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N. Engl. J. Med. 364, 1807–1816 (2011).
pubmed: 21561346
Inoue, H. et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42, 265–271 (2010).
pubmed: 20354937
Modayil, R. J. et al. Peroral endoscopic myotomy: 10-year outcomes from a large, single-center U.S. series with high follow-up completion and comprehensive analysis of long-term efficacy, safety, objective GERD, and endoscopic functional luminal assessment. Gastrointest. Endosc. 94, 930–942 (2021).
pubmed: 33989646
Nabi, Z. et al. Comparison of short versus long esophageal myotomy in cases with idiopathic achalasia: a randomized controlled trial. J. Neurogastroenterol. Motil. 27, 63–70 (2021).
pubmed: 32675389
pmcid: 7786097
Delliturri, A. et al. A Narrative Review of update in per oral endoscopic myotomy (POEM) and endoscopic esophageal surgery. Ann. Transl. Med. 9, 909 (2021).
pubmed: 34164543
pmcid: 8184417
Inoue, H. et al. Per-oral endoscopic myotomy: a series of 500 patients. J. Am. Coll. Surg. 221, 256–264 (2015).
pubmed: 26206634
Akintoye, E. et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy 48, 1059–1068 (2016).
pubmed: 27617421
Onimaru, M. et al. Long-term clinical results of per-oral endoscopic myotomy (POEM) for achalasia: first report of more than 10-year patient experience as assessed with a questionnaire-based survey. Endosc. Int. Open 9, E409–E416 (2021).
pubmed: 33655041
pmcid: 7895648
Repici, A. et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest. Endosc. 87, 934–943.e18 (2018).
pubmed: 29102729
Karyampudi, A. et al. Gastroesophageal reflux after per-oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: a case-control study. United European Gastroenterol. J. 9, 63–71 (2021).
pubmed: 32723068
pmcid: 8259274
Patti, M. G., Tamburini, A. & Pellegrini, C. A. Cardiomyotomy. Semin. Laparosc. Surg. 6, 186–193 (1999).
pubmed: 10684551
Milone, M. et al. Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis. Dis. Esophagus 32, 1–8 (2019).
pubmed: 31274153
Richards, W. O. et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann. Surg. 240, 405–412; discussion 412–415 (2004).
pubmed: 15319712
pmcid: 1356431
Torres-Villalobos, G. et al. Dor vs Toupet fundoplication after laparoscopic Heller myotomy: long-term randomized controlled trial evaluated by high-resolution manometry. J. Gastrointest. Surg. 22, 13–22 (2018).
pubmed: 28924729
Ortiz, A. et al. Very long-term objective evaluation of Heller myotomy plus posterior partial fundoplication in patients with achalasia of the cardia. Ann. Surg. 247, 258–264 (2008).
pubmed: 18216530
Zaninotto, G. et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann. Surg. 248, 986–993 (2008).
pubmed: 19092343
Gossage, J. A. et al. Surveillance endoscopy at five or more years after cardiomyotomy for achalasia. Ann. Surg. 259, 464–468 (2014).
pubmed: 23732271
Chrystoja, C. C. et al. Achalasia-specific quality of life after pneumatic dilation or laparoscopic Heller myotomy with partial fundoplication: a multicenter, randomized clinical trial. Am. J. Gastroenterol. 111, 1536–1545 (2016).
pubmed: 27619832
Ponds, F. A. et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA 322, 134–144 (2019).
pubmed: 31287522
pmcid: 6618792
Sloan, J. A. et al. Treatment experience with a novel 30-mm hydrostatic balloon in esophageal dysmotility: a multicenter retrospective analysis. Gastrointest. Endosc. 92, 1251–1257 (2020).
pubmed: 32417296
Schnurre, L. et al. Short-term outcome after singular hydraulic EsoFLIP dilation in patients with achalasia: a feasibility study. Neurogastroenterol. Motil. 32, e13864 (2020).
pubmed: 32391635
Jung, H. K. et al. 2019 Seoul consensus on esophageal achalasia guidelines. J. Neurogastroenterol. Motil. 26, 180–203 (2020).
pubmed: 32235027
pmcid: 7176504
Werner, Y. B. et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N. Engl. J. Med. 381, 2219–2229 (2019).
pubmed: 31800987
Pratap, N. et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J. Neurogastroenterol. Motil. 17, 48–53 (2011).
pubmed: 21369491
pmcid: 3042218
Salvador, R. et al. Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry. Surg. Endosc. 31, 3510–3518 (2017).
pubmed: 28039638
Kumbhari, V. et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of type III achalasia in 75 patients: a multicenter comparative study. Endosc. Int. Open 3, E195–E201 (2015).
pubmed: 26171430
pmcid: 4486039
Borges, A. A. et al. Pneumatic dilation versus laparoscopic Heller myotomy for the treatment of achalasia: variables related to a good response. Dis. Esophagus 27, 18–23 (2014).
pubmed: 23551592
Fernandez-Ananin, S. et al. What to do when Heller’s myotomy fails? Pneumatic dilatation, laparoscopic remyotomy or peroral endoscopic myotomy: a systematic review. J. Minim. Access. Surg. 14, 177–184 (2018).
pubmed: 29319024
pmcid: 6001296
van Hoeij, F. B. et al. Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia. Gastrointest. Endosc. 87, 95–101 (2018).
pubmed: 28478028
Giulini, L., Dubecz, A. & Stein, H. J. Laparoscopic Heller myotomy after failed POEM and multiple balloon dilatations: better late than never [German]. Chirurg 88, 303–306 (2017).
pubmed: 27928603
Panchanatheeswaran, K. et al. Laparoscopic Heller’s cardiomyotomy: a viable treatment option for sigmoid oesophagus. Interact. Cardiovasc. Thorac. Surg. 16, 49–54 (2013).
pubmed: 23065746
Tyberg, A. et al. Peroral endoscopic myotomy as salvation technique post-Heller: international experience. Dig. Endosc. 30, 52–56 (2018).
pubmed: 28691186
Tang, X. et al. Feasibility and safety of peroral endoscopic myotomy for achalasia after failed endoscopic interventions. Dis. Esophagus 30, dote.12457 (2017).
Ling, T., Guo, H. & Zou, X. Effect of peroral endoscopic myotomy in achalasia patients with failure of prior pneumatic dilation: a prospective case-control study. J. Gastroenterol. Hepatol. 29, 1609–1613 (2014).
pubmed: 24628480
Aiolfi, A. et al. Esophageal resection for end-stage achalasia. Am. Surg. 84, 506–511 (2018).
pubmed: 29712597
Molena, D. & Yang, S. C. Surgical management of end-stage achalasia. Semin. Thorac. Cardiovasc. Surg. 24, 19–26 (2012).
pubmed: 22643658
Eckardt, V. F., Hoischen, T. & Bernhard, G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur. J. Gastroenterol. Hepatol. 20, 956–960 (2008).
pubmed: 18787460
Zaninotto, G. et al. The 2018 ISDE achalasia guidelines. Dis. Esophagus https://doi.org/10.1093/dote/doy071 (2018).
doi: 10.1093/dote/doy071
pubmed: 30169645
Palanivelu, C. et al. Laparoscopic transhiatal esophagectomy for ‘sigmoid’ megaesophagus following failed cardiomyotomy: experience of 11 patients. Dig. Dis. Sci. 53, 1513–1518 (2008).
pubmed: 17934854
Glatz, S. M. & Richardson, J. D. Esophagectomy for end stage achalasia. J. Gastrointest. Surg. 11, 1134–1137 (2007).
pubmed: 17623258
Eckardt, V. F. Clinical presentations and complications of achalasia. Gastrointest. Endosc. Clin. N. Am. 11, 281–292 (2001).
pubmed: 11319062
Taft, T. H. et al. Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity. Neurogastroenterol. Motil. 30, e13287 (2018).
pubmed: 29315993
pmcid: 5992017
Cisternas, D. et al. Fair reliability of eckardt scores in achalasia and non-achalasia patients: psychometric properties of the eckardt spanish version in a multicentric study. Neurogastroenterol. Motil. 32, e13827 (2020).
pubmed: 32100424
Vantrappen, G. & Hellemans, J. Treatment of achalasia and related motor disorders. Gastroenterology 79, 144–154 (1980).
pubmed: 6991359
Dakkak, M. & Bennett, J. R. A new dysphagia score with objective validation. J. Clin. Gastroenterol. 14, 99–100 (1992).
pubmed: 1556441
Taft, T. H. et al. Development and validation of the brief esophageal dysphagia questionnaire. Neurogastroenterol. Motil. 28, 1854–1860 (2016).
pubmed: 27380834
pmcid: 5340311
Cisternas, D. et al. The Brief Esophageal Dysphagia Questionnaire shows better discriminative capacity for clinical and manometric findings than the Eckardt score: results from a multicenter study. Neurogastroenterol. Motil. 34, e14228 (2021).
pubmed: 34342075
Goldacre, M., Benians, R. & Goldacre, R. Esophageal achalasia diagnosed in people previously diagnosed with an eating disorder: epidemiological study using record-linkage. Int. J. Eat. Disord. 54, 2015–2018 (2021).
pubmed: 34405903
Carlson, D. A. et al. Esophageal hypervigilance and visceral anxiety are contributors to symptom severity among patients evaluated with high-resolution esophageal manometry. Am. J. Gastroenterol. 115, 367–375 (2020).
pubmed: 31990697
pmcid: 7071929
Loosen, S. H. et al. Achalasia is associated with a higher incidence of depression in outpatients in Germany. PLoS ONE 16, e0250503 (2021).
pubmed: 33930060
pmcid: 8087033
Ross, D., Richter, J. & Velanovich, V. Health-related quality of life and physiological measurements in achalasia. Dis. Esophagus 30, dote.12494 (2017).
Zhong, C. et al. Quality of life following peroral endoscopic myotomy for esophageal achalasia: a systematic review and meta-analysis. Ann. Thorac. Cardiovasc. Surg. 26, 113–124 (2020).
pubmed: 32132346
pmcid: 7303313
Slone, S. et al. Accuracy of achalasia quality of life and eckardt scores for assessment of clinical improvement post treatment for achalasia. Dis. Esophagus 34, doaa080 (2021).
pubmed: 32875315
Smits, M. et al. Pediatric achalasia in the Netherlands: incidence, clinical course, and quality of life. J. Pediatr. 169, 110–5.e3 (2016).
pubmed: 26616251
Newberry, C. et al. Achalasia patients are at nutritional risk regardless of presenting weight category. Dig. Dis. Sci. 63, 1243–1249 (2018).
pubmed: 29468378
Chino, O. et al. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures. Anticancer. Res. 20, 3717–3722 (2000).
pubmed: 11268444
Leeuwenburgh, I. et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am. J. Gastroenterol. 105, 2144–2149 (2010).
pubmed: 20588263
Tustumi, F. et al. Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis. Dis. Esophagus 30, dox072 (2017).
Sandler, R. S. et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 274, 1359–1362 (1995).
pubmed: 7563560
Zagari, R. M. et al. Risk of squamous cell carcinoma and adenocarcinoma of the esophagus in patients with achalasia: a long-term prospective cohort study in Italy. Am. J. Gastroenterol. 116, 289–295 (2021).
pubmed: 33009050
Markar, S. R. et al. Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study. Dis. Esophagus 32, doy106 (2019).
pubmed: 30809653
Tassi, V. et al. Incidence and risk factors for the development of epidermoid carcinoma in oesophageal achalasia. Eur. J. Cardiothorac. Surg. 55, 956–963 (2019).
pubmed: 30561564
Wu, X. Y. et al. The etiology of achalasia: an immune-dominant disease. J. Dig. Dis. 22, 126–135 (2021).
pubmed: 33583137
El Kafsi, J. et al. Management of achalasia in the UK, do we need new guidelines? Ann. Med. Surg. 12, 32–36 (2016).
Werner, Y. B. et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 65, 899–906 (2016).
pubmed: 25934759